These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33631789)

  • 1. Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells.
    Wawrzyniak M; Morsy Y; Mladenov R; Tontodonati G; Turgay Y; Herwig S; Back J; Mally M; Faridmoayer A; Scharl M
    J Crohns Colitis; 2021 Sep; 15(9):1596-1601. PubMed ID: 33631789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
    Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting.
    Thomann M; Malik S; Kuhne F; Avenal C; Plath F; Bonnington L; Reusch D; Bulau P; Cymer F
    Bioanalysis; 2019 Aug; 11(15):1437-1449. PubMed ID: 31490109
    [No Abstract]   [Full Text] [Related]  

  • 4. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.
    Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F
    MAbs; 2015; 7(5):863-70. PubMed ID: 26067753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
    Naso MF; Tam SH; Scallon BJ; Raju TS
    MAbs; 2010; 2(5):519-27. PubMed ID: 20716959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity in structure and functions of antibody sialylation in the Fc.
    Raju TS; Lang SE
    Curr Opin Biotechnol; 2014 Dec; 30():147-52. PubMed ID: 25032906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells.
    Peipp M; Lammerts van Bueren JJ; Schneider-Merck T; Bleeker WW; Dechant M; Beyer T; Repp R; van Berkel PH; Vink T; van de Winkel JG; Parren PW; Valerius T
    Blood; 2008 Sep; 112(6):2390-9. PubMed ID: 18566325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
    Liu L
    J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
    de Haan N; Reiding KR; Driessen G; van der Burg M; Wuhrer M
    J Proteome Res; 2016 Jun; 15(6):1853-61. PubMed ID: 27161864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis.
    Videira PA; Amado IF; Crespo HJ; Algueró MC; Dall'Olio F; Cabral MG; Trindade H
    Glycoconj J; 2008 Apr; 25(3):259-68. PubMed ID: 18080182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
    Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
    Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
    Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
    Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
    Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
    J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain.
    Raju TS; Scallon B
    Biotechnol Prog; 2007; 23(4):964-71. PubMed ID: 17571902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Fc N-glycan sialylation on IgG structure.
    Zhang Z; Shah B; Richardson J
    MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
    Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
    J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal glycosylation of cystic fibrosis airway epithelial cells.
    Rhim AD; Kothari VA; Park PJ; Mulberg AE; Glick MC; Scanlin TF
    Glycoconj J; 2000 Jun; 17(6):385-91. PubMed ID: 11294504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered N-glycan profile of IgG-depleted serum proteins in Hashimoto's thyroiditis.
    Ząbczyńska M; Link-Lenczowski P; Novokmet M; Martin T; Turek-Jabrocka R; Trofimiuk-Müldner M; Pocheć E
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129464. PubMed ID: 31669586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.